(2S,3R,4R,5S,6R)-2-[3-[[4-(3-bicyclo[3.1.0]hexanyloxy)phenyl]methyl]-4-chlorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | 1417579-40-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2S,3R,4R,5S,6R)-2-[3-[[4-(3-bicyclo[3.1.0]hexanyloxy)phenyl]methyl]-4-chlorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
• CAS: 1417579-40-8
• 化学式: C₂₅H₂₉ClO₆
• 分子量: 460.955
• InChiKey: WDBIPGHUEJEKTC-VJYBBBKGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  32
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  99.4
• 氢给体数：
  4
• 氢受体数：
  6

文献信息

• OPTICALLY PURE BENZYL-4-CHLOROPHENYL-C-GLUCOSIDE DERIVATIVE
  申请人：XUANZHU PHARMA CO., LTD.

  公开号：US20150191502A1

  公开（公告）日：2015-07-09

  The present invention belongs to the field of pharmaceutical technology, more specifically relates to optically pure benzyl-4-chlorophenyl-C-glucoside derivatives represented by formulae (II) and (III), a process for preparing these compounds and intermediates thereof, a pharmaceutical formulation and a pharmaceutical composition containing these compounds, and the use of the optically pure benzyl-4-chlorophenyl-C-glucoside derivative as a sodium glucose co-transporter (SGLT) inhibitor in manufacture of a medicament for treating and/or preventing diabetes mellitus (including insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus) or diabetes-associated diseases (including insulin resistance disease and obesity)

  该发明属于制药技术领域，更具体地涉及由化学式（II）和（III）代表的光学纯苄基-4-氯苯基-C-葡萄糖苷衍生物，以及制备这些化合物及其中间体的方法，包含这些化合物的制药配方和制药组合物，以及将光学纯苄基-4-氯苯基-C-葡萄糖苷衍生物用作钠葡萄糖共转运蛋白（SGLT）抑制剂，用于制造治疗和/或预防糖尿病（包括胰岛素依赖型糖尿病和非胰岛素依赖型糖尿病）或与糖尿病相关疾病（包括胰岛素抵抗症和肥胖症）的药物。
• C-GLYCOSIDE DERIVATIVES
  申请人：Wu Frank

  公开号：US20140128331A1

  公开（公告）日：2014-05-08

  The present invention involves a compound represented by general formula (I), a derivative thereof and a use thereof: wherein R 1 , R 2 , R 3 , R 4 , R 5a , R 5b , R 5c and X are defined as in the description.

  本发明涉及一种由一般式（I）表示的化合物、其衍生物以及其用途：其中R1、R2、R3、R4、R5a、R5b、R5c和X的定义如描述中所述。
• C-glycoside derivative
  申请人：SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

  公开号：US10253010B2

  公开（公告）日：2019-04-09

  The present invention involves a compound represented by general formula (I), a derivative thereof and a use thereof: wherein R1, R2, R3, R4, R5a, R5b, R5c and X are defined as in the description.

  本发明涉及通式 (I) 所代表的化合物、其衍生物及其用途： 其中 R1、R2、R3、R4、R5a、R5b、R5c 和 X 的定义如说明书所述。
• Optically pure benzyl-4-chlorophenyl-C-glucoside derivatives as SGLT inhibitors (diabetes mellitus)
  申请人：Xuanzhu Pharma Co., Ltd.

  公开号：EP2891654B1

  公开（公告）日：2016-06-22
• C-GLYCOSIDE DERIVATIVE
  申请人：XUANZHU PHARMA CO., LTD.

  公开号：US20170101388A1

  公开（公告）日：2017-04-13

  The present invention involves a compound represented by general formula (I), a derivative thereof and a use thereof: wherein R 1 , R 2 , R 3 , R 4 , R 5a , R 5b , R 5c and X are defined as in the description.